Primary Hyperparathyroidism - Requires Further Workup and Likely Surgical Evaluation
This biochemical profile (calcium 10.5 mg/dL with PTH 75 pg/mL) is consistent with primary hyperparathyroidism (PHPT), as the PTH is inappropriately elevated for the calcium level, and you should proceed with comprehensive evaluation for target organ damage to determine surgical candidacy.
Diagnostic Interpretation
Your patient has an elevated calcium (10.5 mg/dL, assuming upper limit of normal ~10.2-10.5 mg/dL depending on lab) with a PTH of 75 pg/mL. While PTH may appear "normal" by reference range, it is inappropriately elevated for the degree of hypercalcemia 1. In hypercalcemia from non-parathyroid causes, PTH should be suppressed (<20 pg/mL). An elevated or "normal" PTH in the setting of hypercalcemia defines PTH-dependent hypercalcemia, which is PHPT 1.
The precise PTH assay generation matters less for classic PHPT diagnosis, as the inappropriateness of PTH relative to calcium is what matters diagnostically 2.
Essential Workup Before Treatment Decisions
Before determining management, you must evaluate for target organ damage per the 2025 French consensus 3:
Mandatory Assessments:
Bone evaluation: DEXA scan at spine, hip, and distal radius
- Look for T-score <-2.5 SD at any site
- Document any prior low-energy fractures
Renal evaluation:
- Renal ultrasound or preferably low-dose CT urography
- Look for nephrolithiasis or nephrocalcinosis
- Calculate eGFR (surgery indicated if <60 mL/min/1.73 m²)
- 24-hour urine calcium (surgery indicated if >250 mg/day in women or >300 mg/day in men)
Vitamin D status: Measure 25-OH vitamin D to exclude secondary hyperparathyroidism component
Confirm diagnosis: Repeat calcium and PTH to ensure consistency
Surgical Indications
Surgery should be offered if ANY of the following are present 3:
- Proven or low-energy fracture OR T-score <-2.5 SD at any site
- Proven renal colic, urolithiasis, or nephrocalcinosis
- eGFR <60 mL/min/1.73 m²
- 24-hour calciuria >250 mg/day (women) or >300 mg/day (men)
- Serum calcium >0.25 mmol/L (1 mg/dL) above upper normal limit
Given your calcium of 10.5 mg/dL, if the upper limit of normal at your laboratory is ≤9.5 mg/dL, this patient already meets surgical criteria based on calcium alone 3.
Pre-Surgical Localization Studies
If surgery is planned, proceed with imaging 3:
First-line: Parathyroid ultrasound PLUS functional imaging
- Functional imaging options: Either dual-isotope (123I/99mTc-sestamibi) scintigraphy with SPECT/CT OR 18F-choline PET/CT
- Both have excellent performance; 18F-choline may be preferred if patient is young (<40 years) or has family history suggesting multiglandular disease 3
If initial imaging negative: Consider 18F-choline PET/CT if sestamibi was done first
Do not order imaging if surgery is not planned 3.
Management if Surgery Not Indicated or Declined
If the patient does not meet surgical criteria or refuses surgery 3:
Observation with monitoring is appropriate
Pharmacological treatment can be considered:
- Cinacalcet has been shown to normalize calcium in 75.8% of PHPT patients unable to undergo surgery 4
- Consider if patient refuses surgery but has progressive disease
Ensure adequate calcium intake: Do not restrict dietary calcium, as this paradoxically increases PTH 5, 6. Maintain 1000-1200 mg/day calcium intake.
Critical Pitfalls to Avoid
Don't assume "normal" PTH excludes PHPT: The key is that PTH is inappropriately elevated relative to calcium 1
Don't restrict calcium intake: This worsens PTH elevation and bone disease 5
Don't order localization imaging before confirming surgical candidacy: Imaging is only useful if surgery is planned 3
Exclude vitamin D deficiency first: Low vitamin D can cause secondary hyperparathyroidism that confounds the picture
Don't use absolute PTH cutoffs across different assays: PTH assay standardization is incomplete, and different generations measure fragments differently 2